Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration Read more
Genequine selects Exothera to support the next stage of its osteoarthritis gene therapy development Read more
Sanofi provides update on Phase 3 study evaluating rilzabrutinib for the treatment of pemphigus Read more
Repligen and Navigo GmbH Announce Launch of Industry-First Protein A Ligand for Purification of pH Sensitive Antibodies Read more
FDA has declined Humanigen’s Emergency Use Authorization (EUA) Request for Lenzilumab in Hospitalized COVID-19 Patients Read more
Recro and BioCorRx Expand Development and Manufacturing Relationship to Support BICX104, an Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder Read more